logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
EDSA
Edesa Biotech, Inc.
5.52
1 x 5.35
1 x 5.72
bid
ask
+
0.28
5.34%
1 @ 04:00 PM
5.54 +0.02 (0.36%)
Ytd288.73%
1y161.61%
5.25
day range
5.57
0.72
52 week range
20.32
Open5.31Prev Close5.24Low5.25High5.57Mkt Cap53.18M
Vol33.51KAvg Vol181.56KEPS-1.34P/E-4.12Forward P/E-0.89
Beta0.84Short Ratio0.76Inst. Own12.20%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg6.36200-d Avg5.001yr Est20.50

EDSA News

Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
globenewswire.com
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Fo

TORONTO, June 11, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Ede

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
Edesa Biotech Announces Exploratory Data For Its Anti-TLR4 Monoclonal Antibody Paridiprubart In Pati

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company developing host-direct

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
globenewswire.com
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Inju

TORONTO, June 05, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biop

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
globenewswire.com
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Con

TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage bioph

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Edesa Biotech Q2 EPS $(0.49) Misses $(0.26) Estimate

Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.49) per share which missed the analyst

Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
globenewswire.com
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopha

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
globenewswire.com
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit

Selection Follows Positive Phase 3 Results for Paridiprubart Demonstrating Statistically Significant
benzinga.com
Edesa Biotech Reaffirms Enrollment Timeline Guidance For Phase 2 Clinical Study Of EB06 In Moderate-

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
globenewswire.com
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biop

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Why Box Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Box Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

Box Inc (BOX) shares jump 6.2% in pre-market trading after beating earnings expectations with $305

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
Reported Earlier: Edesa Biotech Reports Phase 3 Data Show Paridiprubart Cuts 28-Day Mortality To 24%

Results in a population of 278 patients affirm statistically significant mortality reductions
benzinga.com
Edesa Biotech Announces Additional Data From Phase 3 Study Of Paridiprubart

Results in a population of 278 patients affirm statistically significant mortality reductionsBenefit

Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
globenewswire.com
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bioph

Market Today: AI Fears Rattle Stocks; CPI Cools, Rivian Pops
gurufocus.com
Market Today: AI Fears Rattle Stocks; CPI Cools, Rivian Pops

Guru Stock PicksRobert Bruce has made the following transactions:Reduce in NEE by 1.49%Ray Dalio has
benzinga.com
Edesa Biotech Q1 EPS $(0.28) Beats $(0.45) Estimate

Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.28) per share which beat the analyst co

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
globenewswire.com
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bioph
benzinga.com
Edesa Biotech Q4 EPS $(0.32) Misses $(0.27) Estimate

Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.32) per share which missed the analyst

Edesa Biotech Reports Fiscal Year 2025 Results
globenewswire.com
Edesa Biotech Reports Fiscal Year 2025 Results

TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bioph

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $5 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and mai
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Edesa Biotech Announces Upcoming Conference Schedule
globenewswire.com
Edesa Biotech Announces Upcoming Conference Schedule

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bioph
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
Edesa Biotech Results From Phase 3 Trial Of Paridiprubart Meets Primary, Secondary Endpoints With St

Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
globenewswire.com
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bioph
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Edesa Biotech Posts Narrower Loss in Q3
fool.com
Edesa Biotech Posts Narrower Loss in Q3

Edesa Biotech Posts Narrower Loss in Q3
benzinga.com
Edesa Biotech Q3 EPS $(0.25) Beats $(0.29) Estimate

Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.25) per share which beat the analyst co

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
globenewswire.com
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bioph
benzinga.com
HC Wainwright & Co. Assumes Edesa Biotech at Buy, Announces Price Target of $5

HC Wainwright & Co. analyst Yi Chen assumes Edesa Biotech (NASDAQ:EDSA) with a Buy rating and

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
globenewswire.com
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopha

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
globenewswire.com
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biop